U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
Links shared publicly online about this topic.
- 789total visits
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
Baraclude (entecavir) is used for the treatment of chronic hepatitis B. Information from Drugs.com includes Baraclude side effects, interactions and indications.
View full resource at drugs.com
Tags: Liver Condition, Hepatitis, Hepatitis B, Hepatitis B Medication, Drug, FDA, Baraclude
Most Recently Shared on October 19, 2010 at 11:11 pm By:
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patie... http://bit.ly/clcQOM #drug
Advertisement
